Upstate Active Clinical Trials
Study Title:
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of Humira®(Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD) – CAPE
What is the purpose of the study? (in Layman's terms, please describe the study)
The purpose of this study is to collect long term safety information on Humira® (adalimumab), a monoclonal antibody approved for the treatment of Crohn’s Disease in children.Upstate Institutional Review Board (IRB) Number:
789684Study/Protocol ID:
P11-292Study Phase:
N/APatient Age Group:
ChildrenPrincipal Investigator:
Prateek D WaliWho can I contact for more information?
Name: Sharihan Amra
Phone: 315-464-8444
Email: amras@upstate.edu